BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15705630)

  • 1. Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.
    Kingsley GH; Khoshaba B; Smith CM; Choy EH; Scott DL
    Rheumatology (Oxford); 2005 May; 44(5):629-32. PubMed ID: 15705630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis.
    Sokka T; Pincus T
    Arthritis Rheum; 2003 Feb; 48(2):313-8. PubMed ID: 12571838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
    Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
    Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.
    Choy EH; Khoshaba B; Cooper D; MacGregor A; Scott DL
    Arthritis Rheum; 2008 Feb; 59(2):192-9. PubMed ID: 18240256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
    Harrison MJ; Tricker KJ; Davies L; Hassell A; Dawes P; Scott DL; Knight S; Davis M; Mulherin D; Symmons DP
    J Rheumatol; 2005 Dec; 32(12):2330-6. PubMed ID: 16331758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
    Rintelen B; Sautner J; Haindl PM; Andel I; Maktari A; Leeb BF
    Scand J Rheumatol; 2009; 38(5):336-41. PubMed ID: 19585379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy.
    Bingham SJ; Buch MH; Tennant A; Emery P
    Rheumatology (Oxford); 2004 Mar; 43(3):364-8. PubMed ID: 14657509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
    Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
    Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement.
    Taylor WJ; Harrison AA; Highton J; Chapman P; Stamp L; Dockerty J; McQueen F; Jones PB; Ching D; Porter D; Rajapakse C; Rudge SR; Taylor G; Kumar S; Macedo T; Hoy MS
    Rheumatology (Oxford); 2008 Apr; 47(4):514-8. PubMed ID: 18321947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.
    Sany J; Bourgeois P; Saraux A; Durieux S; Lafuma A; Daurès JP; Guillemin F; Sibilia J
    Ann Rheum Dis; 2004 Oct; 63(10):1235-40. PubMed ID: 15361378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.